|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/192 | (2006.01) |
| A61K 31/192 | (2013.01) | ||
| A61P 31/20 | (2006.01) | ||
| A61P 31/20 | (2018.01) |
| (11) | Number of the document | 3892268 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20315150.1 |
| Date of filing the European patent application | 2020-04-10 | |
| (97) | Date of publication of the European application | 2021-10-13 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-17 |
| (46) | Date of publication of the claims translation |
| (72) |
VIDALAIN, Pierre Oliver , FR
LOTTEAU, Vincent , FR
NOUGAIREDE, Antoine , FR
TOURET, Franck , FR
DE LAMBALLERIE, Xavier , FR
ANDRE, Patrice , FR
|
| (73) |
INSERM (Institut National de la Santé et de la
Recherche Médicale) ,
101 rue de Tolbiac, 75013 Paris,
FR
UNIVERSITE CLAUDE BERNARD - LYON 1 , 43, boulevard du 11 novembre 1918, 69100 Villeurbanne, FR CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , 3, rue Michel Ange, 75016 Paris, FR Ecole Normale Supérieure de Lyon , 15 Parvis René Descartes, 69007 Lyon, FR Université d'Aix Marseille , 58, boulevard Charles Livon, 13007 Marseille 7, FR Institut De Recherche Pour Le Développement (IRD) , Immeuble le Sextant 44 Bd Dunkerque CS90009, 13002 Marseille 2, FR |
| (54) | USE OF VIDOFLUDIMUS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS |
| USE OF VIDOFLUDIMUS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS |